BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33807355)

  • 1. The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer.
    Micallef I; Baron B
    Noncoding RNA; 2021 Mar; 7(2):. PubMed ID: 33807355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
    Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and colorectal cancer chemoresistance: New solution for old problem.
    Vaghari-Tabari M; Majidinia M; Moein S; Qujeq D; Asemi Z; Alemi F; Mohamadzadeh R; Targhazeh N; Safa A; Yousefi B
    Life Sci; 2020 Oct; 259():118255. PubMed ID: 32818543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.
    Khalafizadeh A; Hashemizadegan SD; Shokri F; Bakhshinejad B; Jabbari K; Motavaf M; Babashah S
    J Cell Mol Med; 2024 Apr; 28(7):e18197. PubMed ID: 38506091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential.
    Luo ZD; Wang YF; Zhao YX; Yu LC; Li T; Fan YJ; Zeng SJ; Zhang YL; Zhang Y; Zhang X
    World J Gastroenterol; 2023 Jan; 29(1):1-18. PubMed ID: 36683709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research.
    Alharbi KS
    Pathol Res Pract; 2024 Feb; 254():155138. PubMed ID: 38266458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer.
    Yang S; Sun Z; Zhou Q; Wang W; Wang G; Song J; Li Z; Zhang Z; Chang Y; Xia K; Liu J; Yuan W
    Cancer Manag Res; 2018; 10():2249-2257. PubMed ID: 30100756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer.
    Yao F; Huang X; Xie Z; Chen J; Zhang L; Wang Q; Long H; Jiang J; Wu Q
    Carcinogenesis; 2022 Oct; 43(9):895-907. PubMed ID: 35914269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance.
    Lampropoulou DI; Pliakou E; Aravantinos G; Filippou D; Gazouli M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of non-coding RNAs in colorectal cancer, with a focus on its autophagy.
    Chen L; He M; Zhang M; Sun Q; Zeng S; Zhao H; Yang H; Liu M; Ren S; Meng X; Xu H
    Pharmacol Ther; 2021 Oct; 226():107868. PubMed ID: 33901505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.
    Ebrahimi N; Hakimzadeh A; Bozorgmand F; Speed S; Manavi MS; Khorram R; Farahani K; Rezaei-Tazangi F; Mansouri A; Hamblin MR; Aref AR
    Cell Cycle; 2023 Oct; 22(20):2302-2323. PubMed ID: 38009668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Circular RNAs Associated With Chemoresistance in Colorectal Cancer.
    Yao F; Xiang X; Zhou C; Huang Q; Huang X; Xie Z; Wang Q; Wu Q
    Front Genet; 2021; 12():696948. PubMed ID: 34603369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.
    Jiang Z; Hou Z; Liu W; Yu Z; Liang Z; Chen S
    Bioengineered; 2022 Jan; 13(1):810-823. PubMed ID: 34974791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
    Xia M; Zu X; Chen Z; Wen G; Zhong J
    Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
    Tang XJ; Wang W; Hann SS
    Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interaction Between Epigenetic Changes, EMT, and Exosomes in Predicting Metastasis of Colorectal Cancers (CRC).
    Yang M; Sun M; Zhang H
    Front Oncol; 2022; 12():879848. PubMed ID: 35712512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.
    Wang M; Yu F; Chen X; Li P; Wang K
    Mol Ther Nucleic Acids; 2020 Sep; 21():13-27. PubMed ID: 32505000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
    Yang Y; Du Y; Liu X; Cho WC
    Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Coding RNAs in Colorectal Cancer: Their Functions and Mechanisms.
    Jia Z; An J; Liu Z; Zhang F
    Front Oncol; 2022; 12():783079. PubMed ID: 35186731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.